• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病患者的癌症风险

Cancer risks in Crohn disease patients.

作者信息

Hemminki K, Li X, Sundquist J, Sundquist K

机构信息

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

出版信息

Ann Oncol. 2009 Mar;20(3):574-80. doi: 10.1093/annonc/mdn595. Epub 2008 Sep 2.

DOI:10.1093/annonc/mdn595
PMID:18765463
Abstract

BACKGROUND

Patients diagnosed with Crohn disease (CD) are known to be at an increased risk of bowel cancers and lymphoma. CD is an autoimmune disease and we hypothesize that the patients are predisposed to a wider spectrum of cancers.

PATIENTS AND METHODS

A CD research database was constructed by identifying hospitalized CD patients from the Hospital Discharge Register and cancer patients from the Swedish Cancer Registry. Follow-up of 21 788 CD patients first hospitalized during the years 1964-2004 identified 1424 cancer cases. Standardized incidence ratios (SIRs) were calculated by comparing cancers in CD patients with subjects without CD.

RESULTS

In addition to the known sites, many additional sites were in excess in CD patients. These included liver, pancreatic, lung, prostate, testicular, kidney and skin (squamous cell) cancers; nonthyroid endocrine tumors and leukemia. The previously established sites showed the highest SIRs; however, SIRs >2.0 were noted for the novel sites of the liver, testis and kidney. For testicular cancer, the SIR of seminoma was 2.74. Cancer risks were influences by age at first hospitalization for CD but whether the age effects were increasing or decreasing depending on the cancer type.

CONCLUSIONS

This large study identified many novel subsequent cancers in CD patients.

摘要

背景

已知被诊断为克罗恩病(CD)的患者患肠癌和淋巴瘤的风险增加。CD是一种自身免疫性疾病,我们推测这些患者易患更广泛的癌症。

患者与方法

通过从医院出院登记册中识别住院的CD患者以及从瑞典癌症登记处识别癌症患者,构建了一个CD研究数据库。对1964年至2004年期间首次住院的21788例CD患者进行随访,共识别出1424例癌症病例。通过比较CD患者与非CD患者的癌症发病率,计算标准化发病率(SIR)。

结果

除了已知的部位外,CD患者中许多其他部位的癌症发病率也过高。这些部位包括肝癌、胰腺癌、肺癌、前列腺癌、睾丸癌、肾癌和皮肤(鳞状细胞)癌;非甲状腺内分泌肿瘤和白血病。先前确定的部位显示出最高的SIR;然而,肝脏、睾丸和肾脏等新部位的SIR>2.0。对于睾丸癌,精原细胞瘤的SIR为2.74。癌症风险受CD首次住院年龄的影响,但年龄效应是增加还是减少取决于癌症类型。

结论

这项大型研究在CD患者中发现了许多新的后续癌症。

相似文献

1
Cancer risks in Crohn disease patients.克罗恩病患者的癌症风险
Ann Oncol. 2009 Mar;20(3):574-80. doi: 10.1093/annonc/mdn595. Epub 2008 Sep 2.
2
Cancer risks in ulcerative colitis patients.溃疡性结肠炎患者的癌症风险。
Int J Cancer. 2008 Sep 15;123(6):1417-21. doi: 10.1002/ijc.23666.
3
Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden.住院结节病患者的癌症风险:瑞典的一项随访研究。
Ann Oncol. 2009 Jun;20(6):1121-6. doi: 10.1093/annonc/mdn767. Epub 2009 Feb 11.
4
Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden.瑞典基于人群的队列研究:1 型糖尿病住院患者的癌症风险。
Diabet Med. 2010 Jul;27(7):791-7. doi: 10.1111/j.1464-5491.2010.03011.x.
5
Cancer risk in hospitalized rheumatoid arthritis patients.住院类风湿关节炎患者的癌症风险
Rheumatology (Oxford). 2008 May;47(5):698-701. doi: 10.1093/rheumatology/ken130. Epub 2008 Mar 30.
6
Risk of cancer following hospitalization for type 2 diabetes.住院治疗 2 型糖尿病后癌症风险。
Oncologist. 2010;15(6):548-55. doi: 10.1634/theoncologist.2009-0300. Epub 2010 May 17.
7
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.老年起病的炎症性肠病中的癌症:一项基于人群的研究。
Am J Gastroenterol. 2016 Oct;111(10):1428-1436. doi: 10.1038/ajg.2016.304. Epub 2016 Aug 2.
8
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.丹麦糖尿病住院患者人群队列中的癌症发病率。
J Natl Cancer Inst. 1997 Sep 17;89(18):1360-5. doi: 10.1093/jnci/89.18.1360.
9
Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis.医学诊断为花粉症或过敏性鼻炎患者的癌症风险。
Int J Cancer. 2014 Nov 15;135(10):2397-403. doi: 10.1002/ijc.28873. Epub 2014 Apr 25.
10
Italian cancer figures, report 2013: Multiple tumours.《2013年意大利癌症数据报告:多发性肿瘤》
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152.

引用本文的文献

1
Association between inflammatory bowel disease and the risk of liver cancer: a systematic review and meta-analysis.炎症性肠病与肝癌风险之间的关联:一项系统评价和荟萃分析。
Clin Exp Med. 2025 Aug 1;25(1):270. doi: 10.1007/s10238-025-01727-7.
2
Skin cancer prevention in the Polish population during the COVID-19 pandemic.新冠疫情期间波兰人群的皮肤癌预防
Front Public Health. 2025 Jun 20;13:1452043. doi: 10.3389/fpubh.2025.1452043. eCollection 2025.
3
A Thiopurine-like Mutagenic Process Defines TGCT Subtypes.一种硫嘌呤样诱变过程定义了睾丸生殖细胞肿瘤(TGCT)亚型。
bioRxiv. 2025 Jun 12:2025.06.12.655573. doi: 10.1101/2025.06.12.655573.
4
The Complex Relationship between Mechanisms Underlying Inflammatory Bowel Disease, Its Treatment, and the Risk of Lymphomas: A Comprehensive Review.炎症性肠病的潜在机制、其治疗方法与淋巴瘤风险之间的复杂关系:一项全面综述
Int J Mol Sci. 2024 Apr 11;25(8):4241. doi: 10.3390/ijms25084241.
5
The Role of Crohn Disease on Breast Cancer Incidence: A Clinical Analysis.克罗恩病对乳腺癌发病率的影响:一项临床分析
World J Oncol. 2023 Dec;14(6):457-463. doi: 10.14740/wjon1644. Epub 2023 Oct 21.
6
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.炎症性肠病中的肠外癌症:文献综述
Cancers (Basel). 2023 Jul 27;15(15):3824. doi: 10.3390/cancers15153824.
7
Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies.炎症性肠病与前列腺癌发病风险的相关性:队列研究的系统评价和荟萃分析。
Int J Colorectal Dis. 2023 Jun 13;38(1):168. doi: 10.1007/s00384-023-04465-y.
8
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study.克罗恩病合并肛周瘘患者的恶性肿瘤发生率:一项德国回顾性队列研究。
United European Gastroenterol J. 2023 Jul;11(6):520-530. doi: 10.1002/ueg2.12396. Epub 2023 May 4.
9
Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century.北欧国家半个世纪以来结肠癌、直肠癌和小肠癌的生存率
Cancers (Basel). 2023 Feb 3;15(3):991. doi: 10.3390/cancers15030991.
10
Telenutrition for the management of inflammatory bowel disease: Benefits, limits, and future perspectives.用于炎症性肠病管理的远程营养:益处、局限及未来展望。
World J Clin Cases. 2023 Jan 16;11(2):308-315. doi: 10.12998/wjcc.v11.i2.308.